Drugmaker Stocks Slide as Trump Taps Vaccine Skeptic RFK Jr for US Health Job
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy Jr., who has previously spread misinformation on vaccines, to lead the Department of Health and Human Services (HHS).
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
Key Takeaways Vaccine maker stocks fell in Friday morning trading after president-elect Donald Trump said he would nominate ...
U.S. stocks suffered their worst loss since election day as the boost from Donald Trump's victory and a Federal Reserve ...
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid ...
President-elect Donald Trump (played by James Austin Johnson) declared that he’s picking the “most epic cabinet of all time” ...
Pharmaceutical stocks slumped as President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department ...
During the “Saturday Night Live” cold open, a couple of controversial cabinet nominees showed up to the meeting between ...
If confirmed, Robert F. Kennedy Jr. will have broad influence over federal agencies and health care policy — a prospect that worries many in public health given his history of conspiracy theories.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback